Table 5.
Hemodynamics and cardiac physiology parameters
| Parameter | Group | |
|---|---|---|
| Control | Empagliflozin | |
| Systolic BP [mmHg] | 115 ± 17 | 126 ± 14 |
| Diastolic BP [mmHg] | 78 ± 13 | 91 ± 11 |
| HR [bpm] | 454 ± 76 | 374 ± 68 |
| SV [µl] | 98 ± 12 | 112 ± 23 |
| CO [m/min] | 19.7 ± 3.1 | 22.3 ± 3.8 |
| EF [%] | 23.2 ± 2.7 | 25.8 ± 6.2 |
| SW [mmHg*µl] | 6680 ± 2208 | 7175 ± 2822 |
| dp/dt max [mmHg/sec] | 5252 ± 2011 | 5453 ± 441 |
| dp/dt min [mmHg/sec] | − 3324 ± 1547 | − 3417 ± 771 |
BP blood pressure, HR Heart rate, SV stroke volume, CO cardiac output, EF ejection fraction, SW stroke work, dp/dt max and min rate of pressure change at systole and diastole, respectively